Detection of sepsis at the intensive care unit with non-invasive transcutaneous blood gas monitoring.
- Conditions
- blood poisoningsepsis1001981510011954
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Sepsis group:
• Sepsis classified as 2 SIRS criteria and suspected infection
• Signs of hypoperfusion, requiring noradrenaline administration of at least
0.5 µg/min/kg
• Written informed consent.
Control group:
• No fulfillment of 2 SIRS criteria, nor suspected infection
• No signs of hypoperfusion, noradrenaline administration of less than or equal
to 0.5 µg/min/kg
• Written informed consent.
Exclusion Criteria
Sepsis group:
• No sepsis
• Skin condition contraindicating transcutaneous blood gas measurements.
• Absence of written informed consent.
Control group:
• Sepsis classified as 2 SIRS criteria and suspected infection
• Skin condition contraindicating transcutaneous blood gas measurements.
• Absence of written informed consent.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study endpoint is the accuracy determined with the AUC-ROC for the<br /><br>delta PCO2 (PaCO2 - tcPCO2) and delta PO2 (tcPO2 - cPO2) in patients with and<br /><br>without sepsis.</p><br>
- Secondary Outcome Measures
Name Time Method